Overseas equities are outperforming domestic shares for the first time in about 15 years, and some financial pros say it’s ...

Shares of Nasdaq Inc. (NASDAQ:NDAQ) climbed to an all-time peak of $89.71, marking a key achievement for the company. With a ...

U.S. stocks remained mostly higher in Wednesday's final hour of trading, with the S&P 500 on pace to reach another record close for the year on investor optimism over a U.S.-Vietnam trade deal. The ...

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) has successfully completed its merger with Channel Therapeutics ...

In U.S. politics, the Senate passed Trump's tax bill, 51-50, and it is now headed back to the House. The bill is expected to ...

Concurrent with the closing of the merger, the combined company closed on a $50.1 million equity private placement Combined company will operate under the name “Pelthos Therapeutics Inc.” and will ...

“Ligand has been an incredible partner over the past few years, and we look forward to their continued guidance and support as members of the Pelthos board,” commented Scott Plesha, CEO of Pelthos.

Design software company Figma filed to go public in the US, revealing it holds $70 million in Bitcoin ETFs and has $30 ...

HOTEL101 GLOBAL HOLDINGS Corp., the newly listed Nasdaq subsidiary of DoubleDragon Corp. (DD), is expected to account for as ...

Hotel101 Global Pte. Ltd., a subsidiary of DoubleDragon Corp., is ready to push forward with its aggressive global expansion plans following its successful listing at the Nasdaq Stock Exchange.

Effective today, all stock trading, Securities and Exchange Commission filings and market-related information will be reported under the new trading symbol "TAOX." The CUSIP for the Company's common ...

Under the Securities Purchase Agreement, HeartCore may issue up to 2,000 shares of Series A Convertible Preferred Stock to Crom at $1,000 per share, for gross proceeds of $2.0 million, with each share ...